Found: 24
Select item for more details and to access through your institution.
Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high‐risk myeloma patients – a single centre experience.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 420, doi. 10.1111/bjh.17379
- By:
- Publication type:
- Article
Clinical outcome of coronavirus disease 2019 in haemato‐oncology patients.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 2, p. e64, doi. 10.1111/bjh.16852
- By:
- Publication type:
- Article
Clinical proof of concept for a safe and effective NF‐κB‐targeting strategy in multiple myeloma.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 3, p. 588, doi. 10.1111/bjh.15569
- By:
- Publication type:
- Article
Extended follow‐up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (MUK six open label, multi‐centre phase I/II Clinical Trial).
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 3, p. 573, doi. 10.1111/bjh.15551
- By:
- Publication type:
- Article
Durable graft‐versus‐leukaemia effects without donor lymphocyte infusions – results of a phase II study of sequential T‐replete allogeneic transplantation for high‐risk acute myeloid leukaemia and myelodysplasia.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 3, p. 346, doi. 10.1111/bjh.14980
- By:
- Publication type:
- Article
The histone deacetylase inhibitor UCL67022 has potent activity in multiple myeloma and non- Hodgkin lymphoma pre-clinical models.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 1, p. 135, doi. 10.1111/bjh.12456
- By:
- Publication type:
- Article
Long-term survival with low toxicity after allogeneic transplantation for acute myeloid leukaemia and myelodysplasia using non-myeloablative conditioning without T cell depletion.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 4, p. 525, doi. 10.1111/bjh.12402
- By:
- Publication type:
- Article
Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- Journal Article
Advanced Imaging Modalities to Monitor for Cardiotoxicity.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41408-020-00357-4
- By:
- Publication type:
- Article
A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 5, p. 714, doi. 10.1111/bjh.12154
- By:
- Publication type:
- Article
Schedule dependent cytotoxicity of bortezomib and melphalan in multiple myeloma.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 1, p. 111, doi. 10.1111/bjh.12089
- By:
- Publication type:
- Article
T-cell replete fludarabine/cyclophosphamide reduced intensity allogeneic stem cell transplantation for lymphoid malignancies.
- Published in:
- British Journal of Haematology, 2012, v. 157, n. 5, p. 580, doi. 10.1111/j.1365-2141.2012.09106.x
- By:
- Publication type:
- Article
Bile acid malabsorption in patients with graft-versus-host disease of the gastrointestinal tract.
- Published in:
- British Journal of Haematology, 2012, v. 157, n. 3, p. 403, doi. 10.1111/j.1365-2141.2011.09014.x
- By:
- Publication type:
- Article
Multiple Myeloma: State of the Art.
- Published in:
- 2012
- By:
- Publication type:
- Book Review
Re-transplantation after bortezomib-based therapy.
- Published in:
- British Journal of Haematology, 2011, v. 153, n. 5, p. 666, doi. 10.1111/j.1365-2141.2010.08521.x
- By:
- Publication type:
- Article
Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Patterns of recruitment into acute myeloid leukaemia (AML) 15 and outcome for young patients with AML at a single referral centre.
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 1, p. 40, doi. 10.1111/j.1365-2141.2008.07561.x
- By:
- Publication type:
- Article
Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma.
- Published in:
- British Journal of Haematology, 2009, v. 144, n. 6, p. 887, doi. 10.1111/j.1365-2141.2008.07572.x
- By:
- Publication type:
- Article
Bortezomib, doxorubicin and dexamethasone (PAD) front-line treatment of multiple myeloma: updated results after long-term follow-up.
- Published in:
- British Journal of Haematology, 2008, v. 141, n. 4, p. 512, doi. 10.1111/j.1365-2141.2008.06997.x
- By:
- Publication type:
- Article
Posterior reversible encephalopathy syndrome following anti-lymphocyte globulin treatment for severe aplastic anaemia.
- Published in:
- 2006
- By:
- Publication type:
- Other
PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 2005, v. 129, n. 6, p. 755, doi. 10.1111/j.1365-2141.2005.05519.x
- By:
- Publication type:
- Article
Thalidomide in multiple myeloma: current status and future prospects.
- Published in:
- British Journal of Haematology, 2003, v. 120, n. 1, p. 18, doi. 10.1046/j.1365-2141.2003.03902.x
- By:
- Publication type:
- Article